Publications While At Healthpartners
Association of fenofibrate therapy with long-term cardiovascular risk in statin-treated patients with type 2 diabetes
Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
Lancet (London, England).
Map of science